INVESTORS & MEDIA
Corporate Governance
Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Dec 15, 2003 |
VP, Regulatory Development
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,000 | -- | 5,000 |
Dec 15, 2003 |
VP, Regulatory Development
|
VP, Regulatory Development | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 15,000 | -- | 15,000 |
Sep 18, 2013 |
VP Reg Dev & Med Safety
|
VP Reg Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 15,000 | $304.00 | 20,644 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 224 | $177.43 | 11,276 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 430 | $178.27 | 10,846 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 2,600 | $179.43 | 8,246 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 5,010 | $180.67 | 3,236 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 1,515 | $181.47 | 1,721 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 521 | $182.44 | 1,200 |
Nov 30, 2012 |
VP Regulat Dev & Med Safety
|
VP Regulat Dev & Med Safety | Form 4 | Open market or private sale of non-derivative or derivative security | 800 | $183.58 | 400 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.